Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2012 | 7 | 1 | 108-111

Article title

Necrotizing pulmonary aspergillosis caused by anorexic syndrome - a case report


Title variants

Languages of publication



The patient presented is a 44-year-old female treated for cavitary changes in the lung apexes. Due to suspected tuberculosis, treatment began with anti-tuberculosis (AT) drugs, despite negative sputum smears for acid-fast bacilli. During hospitalization, the patient was febrile (up to 38°C), hypotensive, extremely cachectic (32 kg), had a dry cough, increased nitrogen products, hypokalemia and anemia. Because of poor response to the applied AT therapy, bronchoscopic tests were repeated and spores of aspergillus fungus were discovered in the pathohistological findings of transbronchial lung biopsy. The appropriate treatment with amphotericin B and voriconazole was initiated. A psychiatric opinion was requested because we suspected that the patient suffered from the anorexic syndrome (anorexia nervosa). This diagnosis was confirmed by a psychiatrist; her psychiatric treatment began simultaneously with the treatment in our facility. Anorexia was the cause of the cachexia, immunodeficiency and invasive pulmonary aspergillosis. The disorder was not recognized before the manifestation of the somatic disorder. There is little data in the available literature on the association between these two diseases.










Physical description


1 - 2 - 2012
24 - 11 - 2011


  • Faculty of Medicine, Clinic for Lung Diseases ant TBC, 18000, Nis, Serbia
  • Faculty of Medicine, Clinic for Lung Diseases ant TBC, 18000, Nis, Serbia
  • Faculty of Medicine, Clinic for Lung Diseases ant TBC, 18000, Nis, Serbia
  • Faculty of Medicine, Institute for Biochemistry, 18000, Nis, Serbia
  • Faculty of Medicine, Clinic for Lung Diseases ant TBC, 18000, Nis, Serbia
  • Faculty of Medicine, Institute for Biochemistry, 18000, Nis, Serbia
  • Faculty of Medicine, Clinic for Lung Diseases ant TBC, 18000, Nis, Serbia


  • [1] Crompton G.K., Fungal Disease in: Respiratory medicine, Ed Brewis, Gibson and Geddes, Bailliere Tindall, 1990, 1035–1049
  • [2] Binder R., Faling L., Pugath R., Mahasaen C., Snider G., Chronic Necrotizing Pulmonary Aspergillosis: a discrete clinical entity, Medicine, 1982, 61, 109–124 http://dx.doi.org/10.1097/00005792-198203000-00005[Crossref]
  • [3] Richardson M.D. and Warnock D.W., Fungal Infection: Diagnosis and Management, 2nd ed., Blackwell Scientific Publications, Oxford, 1997
  • [4] Warnock D.W. and Richardson M.D. Fungal infection in the compromised patients, 2nd ed., John Wiley & Sons, 1991
  • [5] Brodoefel H., Vogel M., Hebart H., Einsele H., Vonthein R., Claussen C., Horger M., Long-Term CT Follow-Up in 40 Non-HIV Immunocompromised Patients with Invasive Pulmonary Aspergillosis: Kinetics of CT Morphology and Correlation with Clinical Findings and Outcome, ARJ 2006, 187, 404–413
  • [6] Sheehan D.J., Hitchcock C.A., Sibley C.M., Current and Emerging Azole Antifungal Agents, Clin Microbiol Rev, 12, 40–79, 1999 [PubMed]
  • [7] Johnson E.M, Syekelz A, Warnock D.W. In vitro activity voriconazole, itraconazole and amphotericin B against filamentous fungi, Chemother, 1998, 42, 741–745 [WoS]
  • [8] Sharma O.P., Chwogule R., Many faces of pulmonary aspergillosis, Eur Respir J, 1998, 12, 705–715 http://dx.doi.org/10.1183/09031936.98.12030705[Crossref]
  • [9] Walsh T.J., Anaissie E.J., Denning D.W., Herbrecht R., Kontoyiannis D.P., Marr K.A., Vicki A., Treatment of asperillosis: clinical practice guidelines of the Infectious Diseases Society of America (IDSA), Clin Infect Dis, 2008, 46(3), 327–360 http://dx.doi.org/10.1086/525258[Crossref]
  • [10] Thomson G.R., Patterson T.F., Pulmonary asperillosis, Semin Respir Crit Care, 2008, 29(2), 103–110 http://dx.doi.org/10.1055/s-2008-1063849[Crossref]
  • [11] Cason J., Ainley C., Wolstencroft R., Norton K., Thompson R., Cell-mediated immunity in anorexia nervosa, Clin Exp Immunol, 1986, 64(2), 370–375 [PubMed]
  • [12] Reichenberger F., Habicht J.M., Gratwohl A., Tamm M., Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients, Eur Respir J, 2001, 19, 743–755 http://dx.doi.org/10.1183/09031936.02.00256102[Crossref]
  • [13] Marcos A., Varela P., Toro O., Lopez-Vidriero I., Nova E., Madraga D., Casas J., Morante G., Interactions between nutrition and immunity in anorexia nervosa: a 1-year follow-up study, Am J Clin Nutr 1997, 66, 485S–490S
  • [14] Tenholder M., Pike J., Effect of Anorexia nervosa on Pulmonary Immunocompetence, Southern Med J, 1991, 84, 1188–1191 http://dx.doi.org/10.1097/00007611-199110000-00007[Crossref]
  • [15] Shimoni Z., Goldenberg A., Nives M., Fatal invasive pulmonary aspergillosis presenting as profound hypoglycemia in a patient with anorexia nervosa, Eur J Intern Med, 2006, 17(4), 295–297 http://dx.doi.org/10.1016/j.ejim.2005.11.026[Crossref]
  • [16] Denning D.W., Follansbee S.E., Scolaro M., Norris S., Edelstein H., Stevans D.A., Pulmonary Aspergillosis in the Acquired Immunodeficiency Syndrome, New Engl J Med, 1991, 324, 654–662 http://dx.doi.org/10.1056/NEJM199103073241003[Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.